KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Common Equity (2016 - 2025)

Historic Common Equity for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $311.1 million.

  • CareDx's Common Equity rose 1386.81% to $311.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $311.1 million, marking a year-over-year increase of 1386.81%. This contributed to the annual value of $378.4 million for FY2024, which is 4481.15% up from last year.
  • As of Q3 2025, CareDx's Common Equity stood at $311.1 million, which was up 1386.81% from $327.4 million recorded in Q2 2025.
  • Over the past 5 years, CareDx's Common Equity peaked at $479.8 million during Q2 2021, and registered a low of $256.2 million during Q1 2024.
  • Moreover, its 5-year median value for Common Equity was $405.2 million (2023), whereas its average is $385.7 million.
  • In the last 5 years, CareDx's Common Equity soared by 36510.89% in 2021 and then plummeted by 3935.45% in 2023.
  • CareDx's Common Equity (Quarter) stood at $465.9 million in 2021, then decreased by 7.51% to $430.9 million in 2022, then plummeted by 39.35% to $261.3 million in 2023, then skyrocketed by 44.81% to $378.4 million in 2024, then decreased by 17.78% to $311.1 million in 2025.
  • Its Common Equity stands at $311.1 million for Q3 2025, versus $327.4 million for Q2 2025 and $379.3 million for Q1 2025.